Thursday, July 19, 2012 10:54:26 AM
News for 'CHRI' - (China Health Resource Announces Go Global Initiative For New Product Introductions The New Toufeng Migraine Tablet is to be Included)
SICHUAN, China, July 19, 2012 /PRNewswire via COMTEX/ -- China Health Resource,
Inc. (OTCBB: CHRI), today announced is expanding the company's Go Global
Initiative to include the Migraine market and has appointed a task force to be
headed by Ms. Cynthia Bitting to undertake USA strategic alliances under the Go
Global Initiative.
"Response to our newly developed Toufeng Migraine tablet has been overwhelming;
we decided our Go Global Initiative platform must immediately be expanded to
include strategic alliances for this new revolutionary Toufeng Migraine tablet
and other's. Discussions with Herborium Group Inc. have been discontinued by
CHRI," said Mr. Jiayin Wang, Chairman and CEO of CHRI.
"The Company while protecting its Chinese operation franchise, is looking
forward to significant expansion through new product introduction and
commercialization in the USA and globally," says Cynthia Bitting, Head of
Strategic Alliances/Go Global Initiative.
"The Company has experienced strong growth each quarter and while protecting its
high growth franchise is looking forward to continued expansion through new
product introduction and development. Our franchise in our Chinese operations
continues to be strong and demand for our products continues despite a general
slowing in the Chinese economy. Now, our investment in research and development
is beginning to reap rewards with the addition of our new migraine solution,
Toufeng Migraine tablet. CHRI is looking for strong strategic alliances to
expand into new markets. I am very pleased with the appointment of Ms. Cynthia
Bitting to head our Go Global Initiative Strategic Alliances," said Jiayin Wang,
CEO of CHRI.
About CHRI
China Health Resource, Inc. engages in the development, manufacturing,
processing, marketing and sale of raw and pharmaceutical TCM products including
Dahurian Angelica Root (DAR) and Rhizoma Gastrodiae (and other products derived
from the highest quality Chinese herbs). It is the only the provider of GAP
quality DAR in the People's Republic of China under the registered Trademark
Chuan Baizhi(TM). DAR, which is also known as "Bai Zhi" in Mandarin Chinese, is
an herb that is employed as an ingredient in medicine, cosmetics and food, as
well as used in TCM for the treatment of pain, swelling and pustule. The
Company's DAR-related products include the Bailing Capsule and Yisheng Capsule.
The Company was founded in 2001 and has operations in Suining, Sichuan Province.
For more information visit www.chinahealthresource.com
Certain statements in this document regarding financial matters, other than
historical facts, and statements of our expectations, intentions, plans and
beliefs, constitute "forward-looking statements" within the meaning of section
27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act
of 1934, as amended, that are subject to certain events, risks and uncertainties
that may be outside our control. The words "believe", "expect", "anticipate",
"optimistic", "intend", "will", and similar expressions identify forward-looking
statements. The company intends that such proclamations about future
expectations, including future revenues and earnings, future business expansion
plans, and all other forward-looking statements be subject to the safe harbors
created thereby. Since these statements involve risks and uncertainties and are
subject to change at any time, the Company's actual results may differ
materially from expected results. These and other risks and uncertainties
related to our business are described in greater detail in our filings with the
Commission. The foregoing information should be read in conjunction with these
filings. We disclaim any intention or obligation to update or revise any
forward-looking statements. Readers are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date on which they
are made.
Press Contact: Ms. Cynthia BittingContact Tel. +1 314-442-0368(USA)
China Health Resource INC. (USA)Email:
info@chinahealthresource.comwww.chinahealthresource.com
SICHUAN, China, July 19, 2012 /PRNewswire via COMTEX/ -- China Health Resource,
Inc. (OTCBB: CHRI), today announced is expanding the company's Go Global
Initiative to include the Migraine market and has appointed a task force to be
headed by Ms. Cynthia Bitting to undertake USA strategic alliances under the Go
Global Initiative.
"Response to our newly developed Toufeng Migraine tablet has been overwhelming;
we decided our Go Global Initiative platform must immediately be expanded to
include strategic alliances for this new revolutionary Toufeng Migraine tablet
and other's. Discussions with Herborium Group Inc. have been discontinued by
CHRI," said Mr. Jiayin Wang, Chairman and CEO of CHRI.
"The Company while protecting its Chinese operation franchise, is looking
forward to significant expansion through new product introduction and
commercialization in the USA and globally," says Cynthia Bitting, Head of
Strategic Alliances/Go Global Initiative.
"The Company has experienced strong growth each quarter and while protecting its
high growth franchise is looking forward to continued expansion through new
product introduction and development. Our franchise in our Chinese operations
continues to be strong and demand for our products continues despite a general
slowing in the Chinese economy. Now, our investment in research and development
is beginning to reap rewards with the addition of our new migraine solution,
Toufeng Migraine tablet. CHRI is looking for strong strategic alliances to
expand into new markets. I am very pleased with the appointment of Ms. Cynthia
Bitting to head our Go Global Initiative Strategic Alliances," said Jiayin Wang,
CEO of CHRI.
About CHRI
China Health Resource, Inc. engages in the development, manufacturing,
processing, marketing and sale of raw and pharmaceutical TCM products including
Dahurian Angelica Root (DAR) and Rhizoma Gastrodiae (and other products derived
from the highest quality Chinese herbs). It is the only the provider of GAP
quality DAR in the People's Republic of China under the registered Trademark
Chuan Baizhi(TM). DAR, which is also known as "Bai Zhi" in Mandarin Chinese, is
an herb that is employed as an ingredient in medicine, cosmetics and food, as
well as used in TCM for the treatment of pain, swelling and pustule. The
Company's DAR-related products include the Bailing Capsule and Yisheng Capsule.
The Company was founded in 2001 and has operations in Suining, Sichuan Province.
For more information visit www.chinahealthresource.com
Certain statements in this document regarding financial matters, other than
historical facts, and statements of our expectations, intentions, plans and
beliefs, constitute "forward-looking statements" within the meaning of section
27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act
of 1934, as amended, that are subject to certain events, risks and uncertainties
that may be outside our control. The words "believe", "expect", "anticipate",
"optimistic", "intend", "will", and similar expressions identify forward-looking
statements. The company intends that such proclamations about future
expectations, including future revenues and earnings, future business expansion
plans, and all other forward-looking statements be subject to the safe harbors
created thereby. Since these statements involve risks and uncertainties and are
subject to change at any time, the Company's actual results may differ
materially from expected results. These and other risks and uncertainties
related to our business are described in greater detail in our filings with the
Commission. The foregoing information should be read in conjunction with these
filings. We disclaim any intention or obligation to update or revise any
forward-looking statements. Readers are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date on which they
are made.
Press Contact: Ms. Cynthia BittingContact Tel. +1 314-442-0368(USA)
China Health Resource INC. (USA)Email:
info@chinahealthresource.comwww.chinahealthresource.com
Unleash the power of Level 2
Spot liquidity moves with access to US order books.


